Evidence map›Paper›PMID 25156700›Full record

ArticleBiological psychiatry2015

Pyramidal cell selective ablation of N-methyl-D-aspartate receptor 1 causes increase in cellular and network excitability.

Valerie M Tatard-Leitman, Catherine R Jutzeler, Jimmy Suh, John A Saunders, Eddie N Billingslea, Susumu Morita, Rachel White, Robert E Featherstone, Rabindranath Ray, Pavel I Ortinski and 10 more

Open access · greenAbstract read
In one paragraph

Article in Biological psychiatry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
5.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 102 citations in OpenAlex.

  1. Trial
  2. Reduced auditory evoked gamma-band response and schizophrenia-like clinical symptoms under subanesthetic ketamine.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2019
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Histamine HProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  13. Article
  14. Neuronal G protein-gated KAmerican journal of physiology. Cell physiology · 2022
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 1 institution in 1 country.

Valerie M Tatard-LeitmanTranslational Neuroscience Program, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania.
Catherine R JutzelerTranslational Neuroscience Program, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania.
Jimmy SuhTranslational Neuroscience Program, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania.
John A SaundersTranslational Neuroscience Program, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania.
Eddie N BillingsleaTranslational Neuroscience Program, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania.
Susumu MoritaTranslational Neuroscience Program, University of Pennsylvania, Philadelphia, Pennsylvania.
Rachel WhiteDepartment of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania.
Robert E FeatherstoneTranslational Neuroscience Program, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania.
Rabindranath RayDepartment of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania.
Pavel I OrtinskiDepartment of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania.
Anamika BanerjeeDepartment of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania.
Michael J GandalTranslational Neuroscience Program, University of Pennsylvania, Philadelphia, Pennsylvania.
Robert LinTranslational Neuroscience Program, University of Pennsylvania, Philadelphia, Pennsylvania.
Anamaria AlexandrescuTranslational Neuroscience Program, University of Pennsylvania, Philadelphia, Pennsylvania.
Yuling LiangTranslational Neuroscience Program, University of Pennsylvania, Philadelphia, Pennsylvania.
Raquel E GurDepartment of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania.
Karin E Borgmann-WinterDepartment of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania.
Gregory C CarlsonDepartment of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania.
Chang-Gyu HahnDepartment of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania.
Steven J SiegelTranslational Neuroscience Program, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: siegels@upenn.edu.
University of Pennsylvania · US

Funding

NMDA Receptor Hypofunction in the Amygdala of Schizophrenia PatientsP50MH096891 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI BILKER, WARREN B. · 2012 to 2016
$10.6M
SCHIZOPHRENIA: A NEUROPSYCHIATRIC PERSPECTIVET32MH019112 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI GUR, RAQUEL E · 1990 to 2024
$6.2M
Src mediates molecular alterations leading to NMDAR hypofunction in schizophreniaR01MH075916 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI BORGMANN-WINTER, KARIN, HAHN, CHANG-GYU · 2006 to 2019
$3.3M
An Implantable Semiannual Antipsychotic Delivery SystemR01MH074672 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI SIEGEL, STEVEN J · 2007 to 2014
$2.3M
Long-term neurobehavioral effects of ketamine exposure in adolescent miceR01DA023210 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI SIEGEL, STEVEN J · 2008 to 2012
$1.9M
Control of Cocaine Seeking by D1-dependent Modulation of NMDA SignalingK01DA031747 · NIDA · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI ORTINSKI, PAVEL IVANOVICH · 2012 to 2016
$696k
NIDA NIH HHS 5R01DA023210-02NIDA NIH HHS K01 DA031747NIDA NIH HHS K01DA031747NIDA NIH HHS R01 DA023210NIMH NIH HHS P50 MH096891NIMH NIH HHS P50MH096891NIMH NIH HHS R01 MH074672NIMH NIH HHS R01 MH075916NIMH NIH HHS R01MH075916NIMH NIH HHS T32 MH019112NIMH NIH HHS T32MH019112
6 · The paper itself

Abstract

backgroundNeuronal activity at gamma frequency is impaired in schizophrenia (SZ) and is considered critical for cognitive performance. Such impairments are thought to be due to reduced N-methyl-D-aspartate receptor (NMDAR)-mediated inhibition from parvalbumin interneurons, rather than a direct role of impaired NMDAR signaling on pyramidal neurons. However, recent studies suggest a direct role of pyramidal neurons in regulating gamma oscillations. In particular, a computational model has been proposed in which phasic currents from pyramidal cells could drive synchronized feedback inhibition from interneurons. As such, impairments in pyramidal neuron activity could lead to abnormal gamma oscillations. However, this computational model has not been tested experimentally and the molecular mechanisms underlying pyramidal neuron dysfunction in SZ remain unclear.

methodsIn the present study, we tested the hypothesis that SZ-related phenotypes could arise from reduced NMDAR signaling in pyramidal neurons using forebrain pyramidal neuron specific NMDA receptor 1 knockout mice.

resultsThe mice displayed increased baseline gamma power, as well as sociocognitive impairments. These phenotypes were associated with increased pyramidal cell excitability due to changes in inherent membrane properties. Interestingly, mutant mice showed decreased expression of GIRK2 channels, which has been linked to increased neuronal excitability.

conclusionsOur data demonstrate for the first time that NMDAR hypofunction in pyramidal cells is sufficient to cause electrophysiological, molecular, neuropathological, and behavioral changes related to SZ.

Indexed as

AnimalsBeta RhythmBrainCholecystokininEvoked Potentials, AuditoryGamma RhythmGlutamate DecarboxylaseG Protein-Coupled Inwardly-Rectifying Potassium ChannelsMemory, Short-TermMice, KnockoutNerve Tissue ProteinsNesting BehaviorNeural PathwaysParvalbuminsProsencephalonPyramidal CellsCholecystokininGlutamate Decarboxylaseglutamate decarboxylase 1Gprin1 protein, mouseG Protein-Coupled Inwardly-Rectifying Potassium ChannelsKcnj6 protein, mouseNerve Tissue ProteinsParvalbuminsReceptors, AMPAReceptors, N-Methyl-D-AspartateSomatostatinGamma frequencyGIRKHyperexcitabilityNMDAR1Pyramidal neuronsSchizophrenia

Identifiers

PMID25156700
PMCPMC4297754
OpenAlexW2063436381

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.